#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study


Authors: Guttorm Raknes;  Lars Småbrekke
Published in the journal: PLoS ONE 14(10)
Category: Correction
doi: https://doi.org/10.1371/journal.pone.0223545

There are a number of errors in Table 3. The value in column 7 "% points" for the line “LDN x 4+” in the group “All examined medicines” should be -3.3, not 0. Additionally, the p-values in the ninth column “P” are incorrect. Please see the correct Table 3 here.

Tab. 1. The number of users of examined medicines among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.
The number of users of examined medicines among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.

There are a number of errors in S2 Table. The p-values in the ninth column “P” are incorrect. Please view the correct S2 Table below.

Supporting information

S2 Table [pdf]
The number of users of medicines classified as Other DMARDs among patients with rheumatoid and seropositive arthritis one year before and after the first dispense of LDN.


Zdroje

1. Raknes G, Småbrekke L (2019) Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study. PLoS ONE 14(2): e0212460. https://doi.org/10.1371/journal.pone.0212460 30763385


Článok vyšiel v časopise

PLOS One


2019 Číslo 10
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#